RoboticsConfidence BUnited Statesactive

Granza Bio

Reprogramming Immunity for Target-Specific Medicines

Official websitegranzabio.com
RegionSan Francisco, United States
CategoryRobotics / Embodied AI
Funding statusUnknown · Undisclosed
Last updatedJun 11, 2026
Latest signalJun 11, 2026

Status timeline

Funding, product, customer, team, and correction signals
Jun 10, 2026Confidence A
Product0 evidence links

Granza Bio product scope reviewed

Granza Bio public product source reviewed for category placement and current operating focus.

No source evidence matched to this event.
Jun 10, 2026Confidence B
Funding0 evidence links

Granza Bio capital or status signal reviewed

Granza Bio public source reviewed for capital or strategic-status timeline signal.

No source evidence matched to this event.

Funding timeline

Amounts are shown only when disclosed and tied to evidence.
Jun 10, 2026

Unknown

AmountUndisclosed
InvestorsY Combinator profile
EvidenceConfidence B
No source evidence matched to this round.

Source evidence

Public links, short factual summaries, and trust levels

Granza Bio official product profile

Granza Bio official site · official
Confidence A

Granza Bio official source reviewed for product scope, operating focus, and category placement.

Trust APublic review
Open source

Granza Bio capital or status signal

Y Combinator Startup Directory · registry
Confidence B

Granza Bio public capital or strategic-status source reviewed for stage and timeline signal.

Trust BPublic review
Open source

Similar projects

Same category or overlapping tags
Granza Bio company intelligence · Alynt